Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
Abstract Introduction For many, atopic dermatitis (AD) is not adequately controlled with topical regimens. This analysis examined treatment using advanced therapies and associated costs. Methods The IQVIA Health Plan Claims data set was analyzed. Patients aged ≥ 12 years with AD who newly initiated...
Saved in:
Main Authors: | Lawrence F. Eichenfield (Author), Marco DiBonaventura (Author), Jason Xenakis (Author), Marie-Helene Lafeuille (Author), Mei Sheng Duh (Author), Iman Fakih (Author), Mark Levenberg (Author), Joseph C. Cappelleri (Author), Vanja Sikirica (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real‐world treatment patterns of patients with atopic dermatitis in Japan: Analysis of the JMDC Claims Database
by: Kazumasa Kamei, et al.
Published: (2021) -
Treatment preferences among patients with mild-to-moderate atopic dermatitis
by: Kelley Myers, et al.
Published: (2023) -
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis
by: Lawrence F. Eichenfield, et al.
Published: (2024) -
Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
by: Andrew Blauvelt, et al.
Published: (2024) -
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment
by: Steven R. Feldman, et al.
Published: (2024)